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• Patients who are prescribed new 
medications during their acute course of 
treatment often cannot state the name, use, 
and adverse effects of their medications. 
This was the case of a pre-intervention 
sample of 25 5K and 6K patients.
• This lack of knowledge can lead to improper 
self-administration, adverse/non-therapeutic 
effects, interactions, progression of illness, 
or readmission to the hospital.
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• An email was sent to all RNs explaining the 
project. Color reminder cards were placed at each 
patient room computer.
• From Aug. 1-15, the 2 RN champions stated 
name, use, and most relevant adverse effect of a 
new medication to 20 patients and asked each 
patient to teach-back. The RNs kept track of the 
data on a spread sheet. Of the 20 patients, 18 
were able to teach back all name, use, and side 
effect. 1 was only able to say the name.
• Over a week, two RN champions identify a new 
medication education opportunity using the icon in the 
MAR
• RN states name, use, and most relevant adverse effect 
of medication and asks patient to teach-back
• RN documents on new medication education icon on 
the MAR whether the patient (or primary learner) was 
able to teach back medication information
• To make all the staff aware of the initiative, an email 
will be sent to all RNs explaining the project. Color 
reminder cards were placed at each patient room 
computer
• Chart audits were completed to determine how many 
patients effectively taught-back
• P- Alert and oriented medical-surgical patients 
prescribed a new medication
• I- Using teach-back
• C- No explanation 
• O- Patient states new medication’s name, use 
and adverse effects accurately
• Implement teach-back as gold standard for 
new medication education network-wide.
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Using Teach-back to Educate About New Medications
Our literature review strongly suggests that using 
teach-back to educate patients leads to:
• Improved outcomes in disease-specific knowledge, 
adherence, self-efficacy, and self-administration (Ha 
Dinh, Bonner, Clark, Ramsbotham & Hines, 2016)
• Improved patient’s recall of information (Slater, Huang, Dalawari, 
2017), (Send, Schwab, Gauss, Rudofsky, Haefeli, Seidling, 2014)
• Improved comprehension of care and self-
management (Griffey, Shin, Jones, Aginam, Gross, Kinsella, Williams, Carpenter, 
Goodman, Kaphingst, 2015), (Mollazadeh, Hemmati Maslakpak, 2018)
• Improvement in the 30-day readmission rate and
length of stay of the second hospitalization (Peter, Robinson, 
Jordan, Lawrence, Casey, Salas-Lopez, 2015)
EVIDENCE
New Med Teach-Back
Taught back 3/3 (name, use, AND s/e) Taught back 2/3 Only taught back 1/3 Not able to teach back
